Yicheng Xu
Liming Zhao2
Shengyuan Yu- 1Department of Neurology, Aerospace Center Hospital, Beijing, China
- 2Department of Neurology, Changyi People's Hospital, Weifang, China
- 3Department of Neurology, Chinese People's Liberation Army General Hospital, Beijing, China
Background: The association between left atrial size and the risk of stroke has not been fully understood. We performed a meta-analysis of prospective cohort studies to determine whether left atrial enlargement (LAE) is associated with an increased risk of stroke.
Methods: We searched PubMed, EMBASE, Web of Science, and the Cochrane Library through May 2019. Prospective cohort studies were included if they reported hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) of stroke with respect to LAE. All meta-analyses were performed using a random-effects model.
Results: Six studies involving 66,007 participants and 3,549 stroke events were included. Compared with patients without LAE, those with LAE had an increased risk of stroke (adjusted HR 1.68, 95% CI 1.36–2.07). There was also a graded association with stroke relating to LAE (adjusted HR for mild LAE 1.50, 95% CI 0.98–2.28; moderate LAE 1.40, 95% CI 1.12–1.75; and severe LAE 1.59, 95% CI 1.33–1.90). Furthermore, for each increase of 1 cm in left atrial diameter, the odds of stroke were increased by 24% (adjusted HR 1.24, 95% CI 1.03–1.50).
Conclusions: Our meta-analysis demonstrated that LAE is associated with an increased and graded risk of stroke.
Introduction
Stroke is a catastrophic condition with a great burden of disability and death. Furthermore, as the world population is aging, the global burden of stroke will increase dramatically (1). And it has been predicted that there will be almost 12 million stroke deaths and 70 million stroke survivors by 2030 (2). Thus, to identify the high risks of stroke patients and to manage well stroke risk factors have an important individual and social impact.
Studies have found that left atrial size was associated with an increased risk of ischemic stroke and all-cause of deaths despite of controversy (3–5). Additionally, some studies have found that this association between left atrial size and stroke seems to exist independent of atrial fibrillation (AF) (6, 7). Therefore, it is important to identify the association between left atrial size and stroke, which would be helpful to stratify the risk of stroke.
Among various quantification methods of left atrial size, the European Society of Cardiology recommends that left atrial volume indexed to body surface area (LAVi) should be used to predict all-cause mortality and ischemic stroke because of its accuracy and reliability (8), considering that it is simpler, more widely available, and more widely used in clinical practice. Most of studies chose left atrial diameter (LAD) as their measurement. Hereby, we conducted a systematic review and meta-analysis of all the prospective cohort studies to determine the association between LAD and the risk of stroke.
Methods
This meta-analysis was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (9). It was prospectively registered in the PROSPERO registry (CRD42017074455).
Data Sources and Search Strategy
We searched PubMed (from inception to May 2019), EMBASE (from inception to May 2019), Web of Science, and the Cochrane Library Databases (May 2019). The following search terms were used: “left atrial volume” OR “left atrial size” OR “left atrial dimension” OR “left atrial diameter” OR “left atrial dilatation” OR “left atrial hypertrophy” OR “left atrial enlargement” OR “left atria volume” OR “left atria size” OR “left atria dimension” OR “left atria diameter” OR “left atria dilatation” OR “left atria hypertrophy” OR “left atria enlargement” OR “left atrium volume” OR “left atrium size” OR “left atrium dimension” OR “left atrium diameter” OR “left atrium dilatation” OR “left atrium hypertrophy” OR “left atrium enlargement” OR “enlarged left atrium” OR “enlarged left atria” OR “heart atrium enlargement” OR atriomega* AND “cerebral embolism” OR stroke OR “Apoplexy” OR “Brain Vascular Accident” OR CVA OR “Cerebrovascular Accident*” OR “ischemic infarction” OR embolism* OR thromboembolism* OR thrombosis. The Medical Subject Headings (MeSH) search and free-text terms search were conducted with our search strategy. Furthermore, we hand-reviewed reference lists of included studies and review articles to search for more studies. Only those that were published as full-length articles and in English were considered. Two investigators (YCX and LMZ) independently performed the literature search.
Study Selection and Eligibility Criteria
We removed duplicates, screened the titles and abstracts for relevance, and accessed full text to identify eligibility. For inclusion, studies had to fulfill the following criteria: have a prospective cohort design with follow-up >1 year; report relative risks or hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs) of stroke relating to left atrial enlargement (LAE).
Data Extraction
Two authors (YCX and LMZ) independently collected data from all included studies using a standard form. The following information was extracted from each included study: first author, year of publication, country of the study, participant number and characteristics, sex, AF status at baseline, exposure definition, mean length of follow-up, number of stroke events, and covariates in the fully adjusted model.
Quality Assessment
We assessed the quality of each cohort by using the Newcastle–Ottawa Scale (10). This scale consists of three domains: selection, comparability, and outcome. The maximum score for cohort is 9 points. We awarded points of 0 to 3, 4 to 6, and 7 to 9 for low, moderate, and high quality, respectively.
Summary Measures
We described associations using HR or risk ratio (RR) for prospective studies. RR was considered equivalent to HR (11).
Statistical Analysis
We pooled the adjusted HRs and corresponding 95% CIs from each study using a random-effects model. We assessed heterogeneity across studies using the Q statistic and the I2 statistic. The I2 statistic is used to estimate the proportion of total variation across studies due to heterogeneity rather than chance (ranging from 0 to 100%). An I2 value > 50% indicates significant heterogeneity. We also performed subgroup analyses according to LA size to further determine the relationship between LAE and the risk of stroke. To evaluate the publication bias, we constructed a funnel plot to visualize possible asymmetry (12). All statistical analyses were performed with Stata, version 12 (StataCorp, College Station, TX). A P < 0.05 was considered statistically significant.
Result
Literature Search
Our initial search yielded 5,436 records. After screening titles and abstracts, we obtained 44 articles for full-text reviewing. Finally, six studies were eligible for inclusion (Figure 1) (7, 13–17).
Figure 1. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow diagram.
Study Characteristics
The characteristics of the included studies are shown in Table 1. These studies were published between 1995 and 2016. The sample sizes of the cohorts ranged from 593 to 52,639. The mean age of the participants varied from 51 to 73.6 years. Among these six studies, only two studies (14, 15) excluded AF patients from baseline participants. The lengths of follow-up for incident stroke varied between 2.6 and 13 years. All the studies reported the association between LAE and stroke after fully adjusting for traditional cardiovascular risk factors such as age, sex, hypertension, and diabetes. The meta-analysis consisted of 66,007 participants and 3,549 stroke events. The baseline participant characteristics among included studies are shown in Table 2. Quality assessment of each study is outlined in Table 3. The score for all studies is 7 or above with high quality.
Table 1. Characteristics of six prospective studies contributing data to the current analysis.
Table 2. Baseline participant characteristics among included studies.
Table 3. Quality ratings for the six cohort studies included on the basis of Newcastle-Ottawa quality assessment scale.
Left Atrial Enlargement and Stroke
Compared with patients without LAE, those with LAE had an increased risk of stroke (five studies; adjusted HR 1.68, 95% CI 1.36–2.07; Figure 2). Figure 3 shows the association between the LAE grades and risk of stroke. The pooled HR was 1.50 for mild LAE (95% CI 0.98–2.28; two studies), 1.40 for moderate LAE (95% CI 1.12–1.75; two studies), and 1.59 for severe LAE (95% CI 1.33–1.90; two studies). Furthermore, for each increase of 1 cm in LAD, the odds of stroke were increased by 24% (adjusted HR 1.24, 95% CI 1.03–1.50; Figure 4). Visual inspection of the funnel plot showed some asymmetry (Figure 5). Considering that only five studies were included in this meta-analysis, it was hard for us to rule out the publication bias.
Figure 2. Meta-analyses of hazard ratios for the association between left atrial enlargement and stroke.
Figure 3. Meta-analyses of hazard ratios for the association between the severity of left atrial enlargement and stroke.
Figure 4. Meta-analyses of hazard ratios for the association between continuous left atrial diameter and stroke.
Figure 5. Funnel plot with pseudo 95% confidence limits.
Discussion
Our meta-analysis of five prospective cohort studies indicates that LAE is associated with increased risk of stroke. Additionally, we found that the risk of stroke became higher with the increase of the LAD. For each increase of 1 cm in LAD, the odds of stroke were increased by 24%.
The mechanisms related LAE to stroke have not been fully understood. Some hypotheses have been proposed, which might partially explain the association between LAE and stroke. First, LAE may predispose the development of AF (18), which is a well-established risk factor for stroke. Second, LAE was considered as a surrogate marker of other risk factors for cardiovascular events (19, 20) such as hypertension or carotid atherosclerosis, which are significantly associated with the high risk of stroke. Third, LAE may promote blood stasis, which results in the increased risk of potential embolization through induction of thrombus formation (7). Additionally, this theory has been supported by the studies of transesophageal echocardiography (TEE) that LAE was associated with spontaneous echocardiographic contrast and LA thrombus (21).
The investigation of the association between LAE and stroke may have several clinical implications. First, much evidence has been found that the left atrial structure and function were strongly associated with the risk of new-onset AF (22, 23) and intermittent AF (24). Meanwhile, the relationship between the AF (including intermittent AF) and ischemic stroke (which was also includes cryptogenic ischemic stroke) is well-recognized (25, 26). So current techniques for detection AF of stroke patients are expensive and have low yield (27). And studies have found that the measurement of left atrial function could predict AF in stroke patients (28). It may be proposed that the left atrial size could serve as a more ideal and stable predictor than AF/underlying AF in ischemic stroke patients, especially in cryptogenic ischemic stroke, which would be also helpful in differentiating etiological diagnoses of ischemic stroke and treatment of the ischemic stroke: choosing or not choosing oral anticoagulant (OAC) treatment. Second, a study (29) that investigated the relationship between LAE and ischemic stroke had found on TTE that LAE had a satisfying predictive value for left atrial thrombus (LAT) on TEE. Thus, patients will not need to undergo TEE, which is expensive and invasive and has a higher risk of complications. Third, based on the above findings and implications, LAD, as the simplest measurement, can be proposed as an additional risk stratification refinement for patients in predicting ischemic stroke and systemic embolism, (7) which is also helpful in the identification of high-risk patients who could benefit from preventive OAC treatment. Fourth, LAE was considered as a surrogate marker of other risk factors for cardiovascular events. So it may be advocated that physicians can optimize risk factor management through monitoring the change of LAE (30).
Several limitations of this study should be considered. First, the differences of population in the included studies could result in inconsistency between studies. And it might be a significant limitation of our study. However, we only included prospective cohort studies, which helped minimize heterogeneity. Second, as we only included studies published in English, we might neglect studies published in other languages and produce bias. Third, the methodological quality of the selected studies was not uniform. Fourth, we considered that RR was equivalent to HR owing to the small number of the included studies in the present meta-analysis. So the findings of our study should be interpreted cautiously.
Conclusions
In conclusion, our meta-analysis demonstrated that LAE is associated with an increased and graded risk of stroke. Future studies should explore the risk and benefit of thromboprophylaxis in general populations with LAE.
Data Availability Statement
The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the article.
Author Contributions
YX conceived the study, participated in the design, collected the data, performed statistical analyses, and drafted the manuscript. LiZ participated in the design, collected the data, performed statistical analyses, and drafted the manuscript. LvZ and YH performed statistical analyses and helped to draft the manuscript. PW and SY performed statistical analyses and helped to revise the manuscript critically for important intellectual content. All authors read and approved the final manuscript.
Funding
This work was supported by the Ministry of Science and Technology of China (no. 2017YFC1307701).
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Abbreviations
AF, atrial fibrillation; CIs, confidence intervals; HR, hazard ratio; LAD, left atrial diameter; LAVi, left atrial volume indexed to body surface area; MeSH, Medical Subject Headings; OAC, oral anticoagulant; RR, risk ratio; TTE, transesophageal echocardiography.
References
1. Bejot Y, Daubail B, Giroud M. Epidemiology of stroke and transient ischemic attacks: current knowledge and perspectives. Revue Neurol. (2016) 172:59–68. doi: 10.1016/j.neurol.2015.07.013
2. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. (2014) 383:245–54. doi: 10.1016/S0140-6736(13)61953-4
3. Aziz EF, Kukin M, Javed F, Musat D, Nader A, Pratap B, et al. Right ventricular dysfunction is a strong predictor of developing atrial fibrillation in acutely decompensated heart failure patients, ACAP-HF data analysis. J Card Fail. (2010) 16:827–34. doi: 10.1016/j.cardfail.2010.05.004
4. Biteker M, Kayatas K, Basaran O, Dogan V, Ozlek E, Ozlek B. The role of left atrial volume index in patients with a first-ever acute ischemic stroke. J Stroke Cerebrovasc Dis. (2017) 26:321–6. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.023
5. Gardner JD, Skelton WPt, Khouzam RN. Is it time to incorporate the left atrial size to the current stroke risk scoring systems for atrial fibrillation? Curr Prob Cardiol. (2016) 41:251–9. doi: 10.1016/j.cpcardiol.2016.10.004
6. Barnes ME, Miyasaka Y, Seward JB, Gersh BJ, Rosales AG, Bailey KR, et al. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc. (2004) 79:1008–14. doi: 10.4065/79.8.1008
7. Hamatani Y, Ogawa H, Takabayashi K, Yamashita Y, Takagi D, Esato M, et al. Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sci Rep. (2016) 6:31042. doi: 10.1038/srep31042
8. Hypertension EETFftMoA. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. (2013) 31:1925–38. doi: 10.1097/HJH.0b013e328364ca4c
9. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. (2009) 339:b2535. doi: 10.1136/bmj.b2535
10. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed February 5, 2020).
11. Wang D, Li W, Cui X, Meng Y, Zhou M, Xiao L, et al. Sleep duration and risk of coronary heart disease: A systematic review and meta-analysis of prospective cohort studies. Int J Cardiol. (2016) 219:231–9. doi: 10.1016/j.ijcard.2016.06.027
12. Sterne J, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. (2001)54: 1046–55. doi: 10.1016/S0895-4356(01)00377-8
13. Bouzas-Mosquera A, Broullon FJ, Alvarez-Garcia N, Méndez E, Peteiro J, Gándara-Sambade T, et al. Left atrial size and risk for all-cause mortality and ischemic stroke. CMAJ. (2011) 183:E657–64. doi: 10.1503/cmaj.091688
14. Karas MG, Devereux RB, Wiebers DO, Whisnant JP, Best LG, Lee ET, et al. Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study. Stroke. (2012) 43:720–6. doi: 10.1161/STROKEAHA.111.631168
15. Haruki S, Minami Y, Hagiwara N. Stroke and embolic events in hypertrophic cardiomyopathy: risk stratification in patients without atrial fibrillation. Stroke. (2016) 47:936–42. doi: 10.1161/STROKEAHA.115.012130
16. Broughton ST, O'Neal WT, Salahuddin T, Soliman EZ. The influence of left atrial enlargement on the relationship between atrial fibrillation and stroke. J Stroke Cerebrovasc Dis. (2016) 25:1396–402. doi: 10.1016/j.jstrokecerebrovasdis.2016.02.004
17. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation. (1995) 92:835–41. doi: 10.1161/01.CIR.92.4.835
18. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. (1994) 89:724–30. doi: 10.1161/01.CIR.89.2.724
19. Nagarajarao HS, Penman AD, Taylor HA, Mosley TH, Butler K, Skelton TN, et al. The predictive value of left atrial size for incident ischemic stroke and all-cause mortality in African Americans: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. (2008) 39:2701–6. doi: 10.1161/STROKEAHA.108.515221
20. Pierdomenico SD, Pierdomenico AM, Di Carlo S, Di Tommaso R, Cuccurullo F. Left atrial enlargement and risk of ischemic stroke in elderly treated hypertensive patients. Am J Hypertens. (2014) 27:1179–84. doi: 10.1093/ajh/hpu042
21. Providencia R, Botelho A, Trigo J, Quintal N, Nascimento J, Mota P, et al. Possible refinement of clinical thromboembolism assessment in patients with atrial fibrillation using echocardiographic parameters. Europace. (2012) 14:36–45. doi: 10.1093/europace/eur272
22. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. (1997) 96:2455–61. doi: 10.1161/01.CIR.96.7.2455
23. Patel DA, Lavie CJ, Milani RV, Shah S, Gilliland Y. Clinical implications of left atrial enlargement: a review. Ochsner J. (2009) 9:191–6.
24. Kinay O, Nazli C, Ergene O, Dogan A, Gedikli O, Hoscan Y, et al. Time interval from the initiation of the electrocardiographic P wave to the start of left atrial appendage ejection flow: a novel method for predicting atrial fibrillation recurrence. J Am Soc Echocardiogr. (2002) 15:1479–84. doi: 10.1067/mje.2002.127515
25. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. (1991) 22:983–8. doi: 10.1161/01.STR.22.8.983
26. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. (2014) 370:2478–86. doi: 10.1056/NEJMoa1313600
27. Malik S, Hicks WJ, Schultz L, Penstone P, Gardner-Gray J, Katramados AM, et al. Development of a scoring system for atrial fibrillation in acute stroke and transient ischemic attack patients: the LADS scoring system. J Neurol Sci. (2011) 301:27–30. doi: 10.1016/j.jns.2010.11.011
28. Waldenhjort D, Sobocinski Doliwa P, Alam M, Frykman-Kull V, Engdahl J, Rosenqvist M, et al. Echocardiographic measures of atrial function may predict atrial fibrillation in stroke patients. Scand Cardiovasc J. (2016) 50:236–42. doi: 10.1080/14017431.2016.1175657
29. Anaissie J, Monlezun D, Seelochan A, Siegler JE, Chavez-Keatts M, Tiu J, et al. Left atrial enlargement on transthoracic echocardiography predicts left atrial thrombus on transesophageal echocardiography in ischemic stroke patients. BioMed Res Int. (2016) 2016:7194676. doi: 10.1155/2016/7194676
Keywords: left atrial size, stroke, meta-analysis, risk, systematic review
Citation: Xu Y, Zhao L, Zhang L, Han Y, Wang P and Yu S (2020) Left Atrial Enlargement and the Risk of Stroke: A Meta-Analysis of Prospective Cohort Studies. Front. Neurol. 11:26. doi: 10.3389/fneur.2020.00026
Received: 18 October 2019; Accepted: 09 January 2020;
Published: 14 February 2020.
Edited by:
Ashfaq Shuaib, University of Alberta, CanadaReviewed by:
Aristeidis H. Katsanos, McMaster University, CanadaCesare Cuspidi, University of Milano Bicocca, Italy
Copyright © 2020 Xu, Zhao, Zhang, Han, Wang and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Peifu Wang, pfuwang@163.com; Shengyuan Yu, yusy1963@126.com